Opportunity ID: 316780

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-294
Funding Opportunity Title: Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 06, 2019
Last Updated Date: Jun 06, 2019
Original Closing Date for Applications: Nov 12, 2021
Current Closing Date for Applications: Nov 12, 2021
Archive Date: Dec 18, 2021
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
County governments
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology. Additional information concerning programmatic areas at NIDDK is available a www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx and applicants are strongly encouraged to discuss research priorities with the Scientific Contact.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-294.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00251787 Oct 12, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00259291 Oct 12, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269720 Oct 28, 2021 Nov 12, 2021 View

Package 1

Mandatory forms

316780 RR_SF424_2_0-2.0.pdf

316780 PHS398_CoverPageSupplement_4_0-4.0.pdf

316780 RR_OtherProjectInfo_1_4-1.4.pdf

316780 PerformanceSite_2_0-2.0.pdf

316780 RR_KeyPersonExpanded_2_0-2.0.pdf

316780 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

316780 RR_Budget_1_4-1.4.pdf

316780 RR_SubawardBudget30_1_4-1.4.pdf

316780 PHS398_ModularBudget_1_2-1.2.pdf

316780 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

316780 RR_SF424_2_0-2.0.pdf

316780 PHS398_CoverPageSupplement_5_0-5.0.pdf

316780 RR_OtherProjectInfo_1_4-1.4.pdf

316780 PerformanceSite_2_0-2.0.pdf

316780 RR_KeyPersonExpanded_2_0-2.0.pdf

316780 PHS398_ResearchPlan_4_0-4.0.pdf

316780 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

316780 RR_Budget_1_4-1.4.pdf

316780 RR_SubawardBudget30_1_4-1.4.pdf

316780 PHS398_ModularBudget_1_2-1.2.pdf

316780 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

316780 RR_SF424_5_0-5.0.pdf

316780 PHS398_CoverPageSupplement_5_0-5.0.pdf

316780 RR_OtherProjectInfo_1_4-1.4.pdf

316780 PerformanceSite_4_0-4.0.pdf

316780 RR_KeyPersonExpanded_4_0-4.0.pdf

316780 PHS398_ResearchPlan_4_0-4.0.pdf

316780 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

316780 RR_Budget_3_0-3.0.pdf

316780 RR_SubawardBudget30_3_0-3.0.pdf

316780 PHS398_ModularBudget_1_2-1.2.pdf

316780 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T17:50:57-05:00

Share This Post, Choose Your Platform!

About the Author: